Literature DB >> 29238918

Treatment of acute hepatitis C: recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases.

Giovanni B Gaeta1, Massimo Puoti2, Nicola Coppola3, Teresa Santantonio4, Raffaele Bruno5, Antonio Chirianni6, Massimo Galli7.   

Abstract

AIM: This paper is aimed at providing practical recommendations for the management of acute hepatitis C (AHC).
METHODS: This is an expert position paper based on the literature revision. Final recommendations were graded by level of evidence and strength of the recommendations.
RESULTS: Treatment of AHC with direct-acting antivirals (DAA) is safe and effective; it overcomes the limitations of INF-based treatments.
CONCLUSIONS: Early treatment with DAA should be offered when available.

Entities:  

Keywords:  Acute hepatitis C; Direct-acting antivirals; Peginterferon

Mesh:

Substances:

Year:  2017        PMID: 29238918     DOI: 10.1007/s15010-017-1107-z

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  43 in total

1.  Interferon therapy of acute hepatitis C in dialysis patients: meta-analysis.

Authors:  F Fabrizi; V Dixit; P Messa; P Martin
Journal:  J Viral Hepat       Date:  2012-03-30       Impact factor: 3.728

2.  EASL Recommendations on Treatment of Hepatitis C 2016.

Authors: 
Journal:  J Hepatol       Date:  2016-09-22       Impact factor: 25.083

Review 3.  Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.

Authors:  Stéphanie Dominguez; Jade Ghosn; Marc-Antoine Valantin; Aurélie Schruniger; Anne Simon; Philippe Bonnard; Eric Caumes; Gilles Pialoux; Yves Benhamou; Vincent Thibault; Christine Katlama
Journal:  AIDS       Date:  2006-05-12       Impact factor: 4.177

4.  Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals.

Authors:  Martin Vogel; Jacob Nattermann; Axel Baumgarten; Gerd Klausen; Bernhard Bieniek; Knud Schewe; Heiko Jessen; Christoph Boesecke; Michael Rausch; Thomas Lutz; Stefan Fenske; Dietmar Schranzo; Tim Kümmerle; Christoph Schuler; Albert Theisen; Christoph Mayr; Thomas Seidel; Jürgen K Rockstroh
Journal:  Antivir Ther       Date:  2006

5.  Ledipasvir-sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial.

Authors:  Jürgen K Rockstroh; Sanjay Bhagani; Robert H Hyland; Chohee Yun; Hadas Dvory-Sobol; Wei Zheng; Diana M Brainard; Patrick Ingiliz; Thomas Lutz; Christoph Boesecke; Mark Nelson
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-03-01

6.  A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.

Authors:  Hans L Tillmann; Alex J Thompson; Keyur Patel; Manfred Wiese; Hannelore Tenckhoff; Hans D Nischalke; Yuliya Lokhnygina; Ulrike Kullig; Uwe Göbel; Emanuela Capka; Johannes Wiegand; Ingolf Schiefke; Wolfgang Güthoff; Kurt Grüngreiff; Ingrid König; Ulrich Spengler; Jeanette McCarthy; Kevin V Shianna; David B Goldstein; John G McHutchison; Jörg Timm; Jacob Nattermann
Journal:  Gastroenterology       Date:  2010-07-14       Impact factor: 22.682

7.  Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission.

Authors:  Thijs J W van de Laar; Akke K van der Bij; Maria Prins; Sylvia M Bruisten; Kees Brinkman; Thomas A Ruys; Jan T M van der Meer; Henry J C de Vries; Jan-Willem Mulder; Michiel van Agtmael; Suzanne Jurriaans; Katja C Wolthers; Roel A Coutinho
Journal:  J Infect Dis       Date:  2007-06-11       Impact factor: 5.226

8.  HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe.

Authors:  Patrick Ingiliz; Thomas C Martin; Alison Rodger; Hans-Jürgen Stellbrink; Stefan Mauss; Christoph Boesecke; Mattias Mandorfer; Julie Bottero; Axel Baumgarten; Sanjay Bhagani; Karine Lacombe; Mark Nelson; Jürgen K Rockstroh
Journal:  J Hepatol       Date:  2016-09-17       Impact factor: 25.083

9.  Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics.

Authors:  Sanaa M Kamal; Alaa Ismail; Camilla S Graham; Qi He; Jens W Rasenack; Thomas Peters; Ahmed A Tawil; Jutta J Fehr; Khalifa El Sayed Khalifa; Mahmoud M Madwar; Margaret James Koziel
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

10.  Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.

Authors:  Chen-Hua Liu; Wang-Hui Sheng; Hsin-Yun Sun; Szu-Min Hsieh; Yi-Chun Lo; Chun-Jen Liu; Tung-Hung Su; Hung-Chih Yang; Wen-Chun Liu; Pei-Jer Chen; Ding-Shinn Chen; Chien-Ching Hung; Jia-Horng Kao
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

View more
  2 in total

1.  High efficacy of interferon-free therapy for acute hepatitis C in HIV-positive patients.

Authors:  David Chromy; Mattias Mandorfer; Theresa Bucsics; Philipp Schwabl; Bernhard Scheiner; Caroline Schmidbauer; Maximilian Christopher Aichelburg; Peter Ferenci; Michael Trauner; Markus Peck-Radosavljevic; Thomas Reiberger
Journal:  United European Gastroenterol J       Date:  2019-03-06       Impact factor: 4.623

2.  The 'Viennese epidemic' of acute HCV in the era of direct-acting antivirals.

Authors:  David Chromy; David J M Bauer; Benedikt Simbrunner; Matthias Jachs; Lukas Hartl; Philipp Schwabl; Caroline Schwarz; Armin Rieger; Katharina Grabmeier-Pfistershammer; Michael Trauner; Peter Ferenci; Mattias Mandorfer; Michael Gschwantler; Thomas Reiberger
Journal:  J Viral Hepat       Date:  2022-03-15       Impact factor: 3.517

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.